Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype

被引:182
作者
Schnabl, B
Purbeck, CA
Choi, YH
Hagedorn, CH
Brenner, DA
机构
[1] Univ N Carolina, Dept Med, Div Digest Dis & Nutr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA
[3] Emory Univ, Sch Med, Dept Med, Atlanta, GA USA
关键词
D O I
10.1053/jhep.2003.50097
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Limited proliferative capacity is a characteristic of most normal human cells and results in a growth-arrested state, called replicative senescence. Functional expression of the telomerase catalytic subunit (human telomerase reverse transcriptase; hTERT) in human activated hepatic stellate cells (HSCs) rescues them from death with immortalization and maintains an activated HSC phenotype. The aim of this study was to evaluate alterations in gene and protein expression of in vitro aged human activated HSCs and to define the pathway by which senescent-activated HSCs are eliminated in culture. Altered patterns of gene expression in senescent human HSCs were assessed using DNA microarray analysis and compared with early passage HSCs or hTERT immortalized HSCs. Senescent HSCs showed higher expression of inflammation and stress-associated genes as compared with early passage HSCs. Senescent HSCs expressed reduced levels of extracellular matrix proteins, including collagens, tenascin, and fibronectin. TUNEL staining of senescent HSCs showed approximately 21% positive cells, indicating DNA fragmentation and apoptosis. Apoptosis involved the mitochondrial pathway with decreased levels of Bcl-2 and Bcl-x(L) protein, release of cytochrome C, and increased caspase-3 activity. In contrast, 4% to 5% of early activated HSCs or telomerase positive HSCs were TUNEL positive. In conclusion, cultured human HSCs undergo a switch from a fibrogenic to an inflammatory phenotype, suggesting that senescent human HSCs might modulate chronic wound heating processes. Maintenance of telomere length represents an important survival factor for activated human HSCs.
引用
收藏
页码:653 / 664
页数:12
相关论文
共 54 条
[11]   Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment [J].
Dufour, JF ;
DeLellis, R ;
Kaplan, MM .
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (12) :2573-2576
[12]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[13]   Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury [J].
Friedman, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (04) :2247-2250
[14]   Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model [J].
Funk, WD ;
Wang, CK ;
Shelton, DN ;
Harley, CB ;
Pagon, GD ;
Hoeffler, WK .
EXPERIMENTAL CELL RESEARCH, 2000, 258 (02) :270-278
[15]   Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand [J].
Gong, WR ;
Pecci, A ;
Roth, S ;
Lahme, B ;
Beato, M ;
Gressner, AM .
HEPATOLOGY, 1998, 28 (02) :492-502
[16]  
GREENWEL P, 1993, LAB INVEST, V69, P210
[17]   Inhibition of NFKB in activated rat hepatic stellate cells by proteasome inhibitors and an IKB super-repressor [J].
Hellerbrand, C ;
Jobin, C ;
Iimuro, Y ;
Licato, L ;
Sartor, RB ;
Brenner, DA .
HEPATOLOGY, 1998, 27 (05) :1285-1295
[18]  
Hellerbrand C, 1996, HEPATOLOGY, V24, P670
[19]  
Holt SE, 1999, MOL CARCINOGEN, V25, P241, DOI 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.3.CO
[20]  
2-0